- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. doi: 10.3322/caac.21660. PMID: 33538338.
- Clark KR. Bladder cancer: Types, risk factors, diagnosis, and treatment. Radiol Technol. 2022;94(1):46-50. PMID: 36347615.
- Cambier S, Sylvester RJ, Collette L, Gontero P, Brausi MA, van Andel G, et al. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance bacillus Calmette-Guérin. Eur Urol. 2016;69(1):60-9. doi: 10.1016/j.eururo.2015.06.045. PMID: 26210894.
- Hadkhale K, Martinsen JI, Weiderpass E, Kjaerheim K, Sparen P, Tryggvadottir L, et al. Occupational exposure to solvents and bladder cancer: A population-based case control study in Nordic countries. Int J Cancer. 2017;140(8):1736-46. doi: 10.1002/ijc.30593. PMID: 28032642.
- Lipunova N, Wesselius A, Cheng KK, van Schooten FJ, Bryan RT, Cazier JB, et al. Gene-environment interaction with smoking for increased non-muscle-invasive bladder cancer tumor size. Transl Androl Urol. 2020;9(3):1329-37. doi: 10.21037/tau-19-523. PMID: 32676417; PMCID: PMC7354298.
- Sholl J, Sepich-Poore GD, Knight R, Pradeu T. Redrawing therapeutic boundaries: microbiota and cancer. Trends Cancer. 2022;8(2):87-97. doi: 10.1016/j.trecan.2021.10.008. PMID: 34844910; PMCID: PMC8770609.
- Raza MH, Gul K, Arshad A, Riaz N, Waheed U, Rauf A, et al. Microbiota in cancer development and treatment. J Cancer Res Clin Oncol. 2019;145(1):49-63. doi: 10.1007/s00432-018-2816-0. PMID: 30542789.
- Petkevicius V, Lehr K, Kupcinskas J, Link A. Fusobacterium nucleatum: Unraveling its potential role in gastric carcinogenesis. World J Gastroenterol. 2024;30(35):3972-84. doi: 10.3748/wjg.v30.i35.3972. PMID: 39351058; PMCID: PMC11438658.
- Ge Y, Wang X, Guo Y, Yan J, Abuduwaili A, Aximujiang K, et al. Gut microbiota influence tumor development and Alter interactions with the human immune system. J Exp Clin Cancer Res. 2021;40(1):42. doi: 10.1186/s13046-021-01845-6. Erratum in: J Exp Clin Cancer Res. 2021;40(1):334. doi: 10.1186/s13046-021-02131-1. PMID: 33494784; PMCID: PMC7829621.
- Doocey CM, Finn K, Murphy C, Guinane CM. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development. BMC Microbiol. 2022;22(1):53. doi: 10.1186/s12866-022-02465-6. PMID: 35151278; PMCID: PMC8840051.
- Bučević Popović V, Šitum M, Chow CT, Chan LS, Roje B, Terzić J. The urinary microbiome associated with bladder cancer. Sci Rep. 2018;8(1):12157. doi: 10.1038/s41598-018-29054-w. PMID: 30108246; PMCID: PMC6092344.
- Abd-El-Raouf R, Ouf SA, Gabr MM, Zakaria MM, El-Yasergy KF, Ali-El-Dein B. Escherichia coli foster bladder cancer cell line progression via epithelial mesenchymal transition, stemness and metabolic reprogramming. Sci Rep. 2020;10(1):18024. doi: 10.1038/s41598-020-74390-5. PMID: 33093503; PMCID: PMC7581527.
- El-Mosalamy H, Salman TM, Ashmawey AM, Osama N. Role of chronic E. coli infection in the process of bladder cancer- an experimental study. Infect Agent Cancer. 2012;7(1):19. doi: 10.1186/1750-9378-7-19. PMID: 22873280; PMCID: PMC3511874.
- Maddah R, Ghanbari F, Veisi M, Koosehlar E, Shadpirouz M, Basharat Z, et al. Unveiling potential biomarkers for urinary tract infection: An integrated bioinformatics approach. Adv Biomed Res. 2024;13:44. doi: 10.4103/abr.abr_355_23. PMID: 39224398; PMCID: PMC11368229.
- Maljkovic Berry I, Melendrez MC, Bishop-Lilly KA, Rutvisuttinunt W, Pollett S, Talundzic E, et al. Next generation sequencing and bioinformatics methodologies for infectious disease research and public health: Approaches, applications, and considerations for development of laboratory capacity. J Infect Dis. 2020;221(Suppl 3):S292-S307. doi: 10.1093/infdis/jiz286. PMID: 31612214.
- Tomczak K, Czerwińska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015;19(1A):A68-77. doi: 10.5114/wo.2014.47136. PMID: 25691825; PMCID: PMC4322527.
- Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71. doi: 10.1093/nar/gkv1507. PMID: 26704973; PMCID: PMC4856967.
- Chen Y, McCarthy D, Ritchie M, Robinson M, Smyth G, Hall E. edgeR: differential analysis of sequence read count data User’s Guide. [Internet] [cited 2024 October 26]. Available from: https://www.bioconductor.org/packages/devel/bioc/vignettes/edgeR/inst/doc/edgeRUsersGuide.pdf
- Ammari MG, Gresham CR, McCarthy FM, Nanduri B. HPIDB 2.0: a curated database for host-pathogen interactions. Database (Oxford). 2016;2016:baw103. doi: 10.1093/database/baw103. PMID: 27374121; PMCID: PMC4930832.
- Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape StringApp: Network analysis and visualization of proteomics data. J Proteome Res. 2019;18(2):623-32. doi: 10.1021/acs.jproteome.8b00702. PMID: 30450911; PMCID: PMC6800166.
- Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638-D646. doi: 10.1093/nar/gkac1000. PMID: 36370105; PMCID: PMC9825434.
- Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, et al. Gene set knowledge discovery with Enrichr. Curr Protoc. 2021;1(3):e90. doi: 10.1002/cpz1.90. PMID: 33780170; PMCID: PMC8152575.
- van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20(5):287-304. doi: 10.1038/s41571-023-00744-3. PMID: 36914746.
- Snell KIE, Ward DG, Gordon NS, Goldsmith JC, Sutton AJ, Patel P, et al. Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification. Oncotarget. 2018;9(38):25244-53. doi: 10.18632/oncotarget.25397. PMID: 29861867; PMCID: PMC5982738.
- Halaseh SA, Halaseh S, Alali Y, Ashour ME, Alharayzah MJ. A review of the etiology and epidemiology of bladder cancer: All you need to know. Cureus. 2022;14(7):e27330. doi: 10.7759/cureus.27330. PMID: 36042998; PMCID: PMC9411696.
- Markowski MC, Boorjian SA, Burton JP, Hahn NM, Ingersoll MA, Maleki Vareki S, et al. The microbiome and genitourinary cancer: A collaborative review. Eur Urol. 2019;75(4):637-46. doi: 10.1016/j.eururo.2018.12.043. PMID: 30655087; PMCID: PMC9774685.
- Nadler N, Kvich L, Bjarnsholt T, Jensen JB, Gögenur I, Azawi N. The discovery of bacterial biofilm in patients with muscle invasive bladder cancer. APMIS. 2021;129(5):265-70. doi: 10.1111/apm.13097. PMID: 33205550.
- Borghi A, Verstrepen L, Beyaert R. TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death. Biochem Pharmacol. 2016;116:1-10. doi: 10.1016/j.bcp.2016.03.009. PMID: 26993379.
- Schneider AT, Gautheron J, Feoktistova M, Roderburg C, Loosen SH, Roy S, et al. RIPK1 suppresses a TRAF2-dependent pathway to liver cancer. Cancer Cell. 2017;31(1):94-109. doi: 10.1016/j.ccell.2016.11.009. PMID: 28017612.
- Ermine K, Yu J, Zhang L. Role of Receptor Interacting Protein (RIP) kinases in cancer. Genes Dis. 2021;9(6):1579-93. doi: 10.1016/j.gendis.2021.10.007. PMID: 36157481; PMCID: PMC9485196.
- Liu Y, Liu T, Lei T, Zhang D, Du S, Girani L, et al. RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review). Int J Mol Med. 2019;44(3):771-86. doi: 10.3892/ijmm.2019.4244. PMID: 31198981; PMCID: PMC6658002.
- Van Quickelberghe E, De Sutter D, van Loo G, Eyckerman S, Gevaert K. A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. Sci Data. 2018;5:180289. doi: 10.1038/sdata.2018.289. PMID: 30561431; PMCID: PMC6298254.
- Tortola L, Nitsch R, Bertrand MJM, Kogler M, Redouane Y, Kozieradzki I, et al. The tumor suppressor hace1 is a critical regulator of TNFR1-mediated cell fate. Cell Rep. 2016;15(7):1481-92. doi: 10.1016/j.celrep.2016.04.032. Erratum in: Cell Rep. 2016;16(12):3414. doi: 10.1016/j.celrep.2016.08.072. PMID: 27160902; PMCID: PMC4893156.
- Vection S, O'Callaghan D, Keriel A. CD98hc in host-pathogen interactions: roles of the multifunctional host protein during infections. FEMS Microbiol Rev. 2022;46(5):fuac023. doi: 10.1093/femsre/fuac023. PMID: 35595511.
- Jing J, Wang B, Liu P. The functional role of SEC23 in vesicle transportation, autophagy and cancer. Int J Biol Sci. 2019;15(11):2419-26. doi: 10.7150/ijbs.37008. PMID: 31595159; PMCID: PMC6775307.
|